Positions

Overview

  • Dr. Wallace is a native of Alabama. He received his BS in Spanish from the University of Alabama at Birmingham (UAB). He graduated AOA from medical school at UAB. He completed his residency training at UAB as well after which he served as Chief Medical Resident. He then pursued a nephrology fellowship at Vanderbilt University and served as Chief Nephrology fellow. After his fellowship, Dr. Wallace joined the faculty at UAB. Currently, he is the UAB Medical Director of Telehealth, Director of the UAB Home Dialysis Program, and co-director of the UAB Fabry Disease Clinic. Since becoming faculty, his research has been focused on eliminating geographic and socioeconomic barriers which prevents patients from accessing specialized care. Primarily, he has focused on telemedicine in the provision of care in home dialysis and rare diseases such as Fabry disease, a rare genetic disease. Using the platform of telemedicine established for his studies on home dialysis, he is focused on creating a network and establishing processes by which physicians at the University of Alabama at Birmingham could provide medical expertise across the state of Alabama using telemedicine thus increasing access to care to patients who due to geographic and/or financial constraints may not be able to travel to UAB. It is his hope that with these studies, the physician workforce distribution issues can be addressed and access to care across the country can be improved.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Exploring Barriers and Potential Solutions in Home Dialysis: An NKF-KDOQI Conference Outcomes ReportAmerican Journal of Kidney Diseases.  73:363-371. 2019
    2019 Remote Patient Management in Home Dialysis: Planning Considerations for the FutureContributions to Nephrology.  197:154-162. 2019
    2018 Clinical parameters, LysoGb3, podocyturia, and kidney biopsy in children with Fabry disease: is a correlation possible?Pediatric Nephrology.  33:2095-2101. 2018
    2018 Fabry disease revisited: Management and treatment recommendations for adult patientsMolecular Genetics and Metabolism.  123:416-427. 2018
    2017 Perspectives from the kidney health initiative on advancing technologies to facilitate remote monitoring of patient self-care in RRTClinical Journal of the American Society of Nephrology.  12:1900-1909. 2017
    2017 Conjunctival lymphangiectasia associated with classic Fabry diseaseBritish Journal of Ophthalmology2017
    2017 Home dialysis utilization among racial and ethnic minorities in the United States at the National, Regional, and state levelPeritoneal Dialysis International.  37:21-29. 2017
    2017 Remote Patient Management for Home Dialysis PatientsKidney International Reports.  2:1009-1017. 2017
    2017 Telehealth in the Delivery of Home Dialysis Care: Catching up With TechnologyAdvances in Renal Replacement Therapy.  24:12-16. 2017
    2016 Chronic massive pneumoperitoneumKidney International.  90:1386. 2016
    2016 Urinary podocyte loss is increased in patients with fabry disease and correlates with clinical severity of fabry nephropathyPLoS ONE.  11. 2016
    2016 Catheter insertion and perioperative practices within the ISPD North American Research ConsortiumPeritoneal Dialysis International.  36:382-386. 2016
    2016 Gastrointestinal involvement in Fabry disease: So important, yet often neglectedClinical Genetics.  89:5-9. 2016
    2015 Appendiceal tissue confirmation of Fabry's diseaseKidney International.  88:417. 2015
    2015 Late onset variants in Fabry disease: Results in high risk population screenings in ArgentinaMolecular Genetics and Metabolism Reports.  4:19-24. 2015
    2015 Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritisClinical Kidney Journal.  8:445-448. 2015
    2014 Is a home dialysis unit really just around the corner in the United States?Peritoneal Dialysis International.  34:677. 2014
    2014 Immune profile of IgA-dominant diffuse proliferative glomerulonephritisClinical Kidney Journal.  7:479-483. 2014
    2014 Economic evaluation of urgent-start peritoneal dialysis versus urgent-start hemodialysis in the United StatesMedicine.  93:e293. 2014
    2013 Dasatinib-induced nephrotic-range proteinuriaAmerican Journal of Kidney Diseases.  61:1026-1031. 2013
    2013 Imatinib: Novel treatment of immune-mediated kidney injuryJournal of the American Society of Nephrology.  24:694-701. 2013
    2013 Pathologic femur fracture due to a brown tumor in a patient with secondary hyperparathyroidism and vitamin D-resistant ricketsAmerican Journal of Kidney Diseases.  61:337-341. 2013
    2012 "Different strokes for different folks"Journal of Hospital Medicine.  7:258-261. 2012
    2012 Imatinib therapy for non-infection-related type II cryoglobulinemia with membranoproliferative glomerulonephritisAmerican Journal of Kidney Diseases.  59:122-125. 2012

    Research Overview

  • Telehealth
    Fabry Disease and other rare genetic kidney disease
    Home Dialysis
    Kidney Disease
  • Principal Investigator On

    Investigator On

  • Private Grant  awarded by ACHILLION PHARMACEUTICALS INC 2018 - 2022
  • Private Grant  awarded by REATA PHARMACEUTICALS 2018 - 2022
  • Private Grant  awarded by REATA PHARMACEUTICALS 2017 - 2020
  • Private Grant  awarded by NXSTAGE MEDICAL, INC. 2015
  • Education And Training

  • Doctor of Medicine, University of Alabama at Birmingham 2006
  • Bachelor of Arts in Spanish and Iberian Studies, University of Alabama at Birmingham 2001
  • UAB Hospital, Internship 2007
  • UAB Hospital, Residency 2009
  • Vanderbilt University Medical Center, Postdoctoral Fellowship 2012
  • Full Name

  • Eric Wallace